Viridian Therapeutics Inc (VRDN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Sales | 256 | 216 | 214 | 208 | 1,090 |
| Gross Profit | 256 | 216 | 214 | 208 | 1,090 |
| Operating Expenses | 29,820 | 26,105 | 29,295 | 14,342 | 19,088 |
| Operating Income | -29,564 | -25,889 | -29,081 | -14,134 | -17,998 |
| Interest Expense | 154 | 0 | 0 | 0 | 0 |
| Other Income | 227 | 196 | 135 | 91 | 34 |
| Pre-tax Income | -29,491 | -25,693 | -28,946 | -14,043 | -17,964 |
| Net Income Continuous | -29,491 | -25,693 | -28,946 | -14,043 | -17,964 |
| Net Income | $-29,491 | $-25,693 | $-28,946 | $-14,043 | $-17,964 |
| EPS Basic Total Ops | -1.06 | -0.98 | -0.29 | -1.25 | -2.21 |
| EPS Basic Continuous Ops | -1.06 | -0.98 | -0.28 | -1.26 | -2.22 |
| EPS Diluted Total Ops | -1.06 | -0.98 | -0.29 | -1.25 | -2.21 |
| EPS Diluted Continuous Ops | -1.06 | -0.98 | -0.28 | -1.26 | -2.22 |
| EBITDA(a) | $-29,247 | $-25,575 | $-28,799 | $-13,870 | $-17,724 |